Updated on 27 August 2014
Sapiens SBS is a developer of deep brain stimulation technologies
Singapore: Global medtech giant, Medtronic, has acquired Netherland-based Sapiens Steering Brain Stimulation (Sapiens SBS), developer of deep brain stimulation (DBS) technologies for approximately USD200 million in an all-cash transaction.
The acquisition of Sapiens SBS is intended to supplement Medtronic's capabilities in modulation of brain function.
Sapiens SBS is developing a DBS system that features an advanced DBS lead with 40 individual stimulation points. This advanced system is designed to allow more precise stimulation of the intended target in the brain and may potentially result in reduced procedure time and fewer stimulation-induced side effects.
Employees at the Eindhoven facility will continue to work toward bringing this technology to market. In the future, the site will serve as a global research and development center for Medtronic's Neuromodulation business, complementing our existing R&D operations.
Medtronic and Sapiens SBS will work to finalize product development and begin clinical research to integrate these technologies into an expanded portfolio of DBS products within Medtronic's Neuromodulation business.